Soda ban at work shrinks waistlines? new study investigates
NCT ID NCT05972109
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a two-part approach to help employees lose belly fat and improve insulin sensitivity: a workplace ban on sugary drinks and a single counseling session. Over 600 full-time employees who drank at least three sugary beverages a week took part. Researchers measured changes in waist circumference and insulin sensitivity over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Workplace sales ban on sugary drinks and brief motivational counseling
What this could lead to
If successful, this approach could offer a simple, workplace-based strategy to help reduce obesity and improve metabolic health in employees.
What could go wrong
This is a completed study, but results may not apply to all workplaces or populations. The intervention is environmental and behavioral, so individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sutter Health/California Pacific Medical Center Research Institute
San Francisco, California, 94115, United States